Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 Nov;63(11):2864-2873.
doi: 10.1007/s10620-018-5222-1. Epub 2018 Aug 3.

Impaired Quality of Life, Work, and Activities Among Adults with Clostridium difficile Infection: A Multinational Survey

Affiliations
Multicenter Study

Impaired Quality of Life, Work, and Activities Among Adults with Clostridium difficile Infection: A Multinational Survey

Kirstin Heinrich et al. Dig Dis Sci. 2018 Nov.

Abstract

Background: Evidence of humanistic detriments of Clostridium difficile infection (CDI) remains limited.

Aims: To assess humanistic burden associated with CDI.

Methods: Self-reported National Health and Wellness Survey data between 2013 and 2016 were analyzed for the USA, five European countries, China, and Brazil. Outcome measures included SF-36v2® for health-related quality of life (HRQoL) and Work Productivity and Activity Impairment questionnaire. Respondents (≥ 18 years old) were classified as (1) currently treated doctor-diagnosed CDI (C-CDI), (2) doctor-diagnosed prior CDI (P-CDI), or (3) never experienced CDI (NO-CDI). Regression modeling assessed the association between CDI status and outcomes, adjusting for potential confounders.

Results: Of 352,780 respondents, 299, 2111, and 350,370 met the criteria for C-CDI, P-CDI, and NO-CDI, respectively, with 45% of the total from the USA. C-CDI and P-CDI respondents were older, were less often employed and had more comorbidities than those with NO-CDI. After adjustment for covariates, C-CDI and P-CDI had significantly lower HRQoL relative to NO-CDI for mental (MCS 39, 43 vs. 46) and physical (PCS 39, 41 vs. 46) component summary scores, and health utility (SF-6D 0.58, 0.64 vs. 0.71) (all p < 0.05), meeting common thresholds for minimally important differences. Those with C-CDI and P-CDI reported missing more work (21, 16 vs. 8%), greater impairment while working (43, 34 vs. 22%), and more activity impairment (61, 49 vs. 34%) than those with NO-CDI (all p < 0.05), respectively.

Conclusions: CDI is associated with meaningfully worse HRQoL and greater impairment to work and activities compared with NO-CDI. The impairment directly attributable to CDI requires further evaluation.

Keywords: Clostridium difficile; Outcomes; Quality of life; Questionnaire; Survey; Work productivity.

PubMed Disclaimer

Conflict of interest statement

HK, YH, VJ, CR, and HJ are employees and stockholders of Pfizer, Inc., the study sponsor. ZM has received compensation as a consultant to Pfizer, Inc., including for the development of this manuscript. She has also received research and/or consulting funding from Merck, The Medicines Company, Astellas, Melinta, Tetraphase, and Paratek. Editorial support was provided by Scott Vuocolo of Pfizer, Inc.

Figures

Fig. 1
Fig. 1
Sample diagram
Fig. 2
Fig. 2
Unadjusted SF-36v2® norm-based mean health domain scores by CDI status. *Statistically significant difference meeting MID criteria versus NO-CDI, tstatistically significant difference versus P-CDI, Δmeeting MID criteria versus P-CDI
Fig. 3
Fig. 3
Adjusted mean SF-36v2® summary scores by CDI status. * Statistically significant difference meeting MID criteria versus NO-CDI, t statistically significant difference meeting MID criteria versus P-CDI
Fig. 4
Fig. 4
Adjusted mean health utility by CDI status. * Statistically significant difference meeting MID criteria versus NO-CDI, t statistically significant difference meeting MID criteria versus P-CDI
Fig. 5
Fig. 5
Adjusted mean work and activity impairment by CDI status. * Statistically significant difference versus NO-CDI, differences between P-CDI and C-CDI were not statistically significant

References

    1. Keller JM, Surawicz CM. Clostridium difficile infection in the elderly. Clin Geriatr Med. 2014;30:79–93. doi: 10.1016/j.cger.2013.10.008. - DOI - PubMed
    1. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372:825–834. doi: 10.1056/NEJMoa1408913. - DOI - PMC - PubMed
    1. Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol. 2011;32:387–390. doi: 10.1086/659156. - DOI - PubMed
    1. Centers for Disease Control and Prevention [CDC] Antibiotic resistance threats in the United States. Washington, DC: Centers for Disease Control and Prevention; 2013.
    1. Chitnis A, Holzbauer S, Belflower R, et al. Epidemiology of community-associated Clostridium difficile infection, 2009–2011. JAMA Intern Med. 2013;173:1359–1367. doi: 10.1001/jamainternmed.2013.7056. - DOI - PMC - PubMed

Publication types

LinkOut - more resources